Development and Progression of Alcohol-Associated Liver Disease: Effect of Aging
酒精相关肝病的发生和进展:衰老的影响
基本信息
- 批准号:10526259
- 负责人:
- 金额:$ 24.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-28 至 2028-01-31
- 项目状态:未结题
- 来源:
- 关键词:Adipose tissueAdvanced DevelopmentAgeAgingAlcohol consumptionAlcoholic Liver DiseasesAlcoholsAnimalsBacterial TranslocationBiologicalBody CompositionCell physiologyChronicCirculationCirrhosisClinicalDefectDevelopmentDietDisease OutcomeDisease ProgressionDoseEatingElderlyEndothelial CellsEndotoxinsEnergy MetabolismEthanolExhibitsExperimental DesignsExposure toExtrahepaticFunctional disorderGastrointestinal tract structureGenderGeneticHeavy DrinkingHepaticHepatic Stellate CellHepatocyteHormonesImpairmentInflammation MediatorsInsulinInvestigationKupffer CellsLife StyleLipolysisLiverLiver CirculationLiver diseasesMetabolismMethodsMorbidity - disease rateMotor ActivityMucous MembraneNebraskaNonesterified Fatty AcidsOrganPathogenesisPathogenicityPathologyPatientsPatternPersonsPhysiologicalPlayPrimary carcinoma of the liver cellsRecording of previous eventsResearchRisk FactorsRodentRoleSamplingSeveritiesSeverity of illnessSteatohepatitisStructureTestingVirus DiseasesWater consumptionadipokinesadiponectinage effectaging populationalcohol exposurealcohol misusealcohol responsebiobankbody systemcell typechronic alcohol ingestionchronic liver diseasediet and exercisedisease phenotypedrinkingglucose uptakegut microbiotainsightintestinal barrierjuvenile animalliver injurymortalityolder patientsimple steatosistrend
项目摘要
Alcohol-associated liver disease (ALD) is a major cause of morbidity and mortality worldwide. It has an array of
liver pathologies that ranges from simple fatty liver to more severe forms of liver injury such as steatohepatitis,
cirrhosis, and hepatocellular carcinoma. Many extrahepatic factors including genetics, gender, lifestyle (diet
and exercise) and exposures to viral infections determine the disease phenotype and outcome. Equally
important in ALD pathogenesis and progression is the associated dysfunction of other organs. It is now well-
documented that the alcohol-induced changes in the gut microbiota and disruption of the intestinal barrier
integrity resulting in the increased translocation of bacterial-derived byproducts into the portal-hepatic
circulation plays a crucial pathogenic role in ALD progression. In adipose tissue, chronic ethanol consumption
enhances lipolysis, impairs insulin-activated glucose uptake, reduces secretion of protective adipokines, and
enhances release of pro-inflammatory mediators, all of which contribute to ALD pathogenesis.
Aging is a predominant risk factor for the development of advanced chronic liver diseases. Emerging evidence
indicates that advanced age is associated with alterations to the hepatic structure and impairment of cellular
functions. There are also aging-related detrimental changes in adipose tissue as well as in the composition/
stability of gut microbiota and barrier integrity. Many of these aging-related alterations in the elderly resemble
ethanol-induced defects in the liver, adipose and gut organ systems.
Based on these considerations we hypothesize that aging-related structural and functional changes in the
gastrointestinal tract, adipose and liver in older subjects promote a faster progression of ALD than in
younger subjects. Here, we propose to conduct an in-depth study to examine the effect of aging on ALD
severity. This study is warranted given the upward trend for heavy drinking among the elderly and the global
expansion in the aging population which is predicted to double to over 1.5 billion persons by 2050.
To test our hypothesis, we propose the following Specific Aims:
Specific Aim 1: Examine the aging-related structural and functional changes in the gastrointestinal tract,
adipose and liver of ethanol-fed rodents
Specific Aim 2: Gain mechanistic insight into how ethanol administration to older and younger animals for
the same duration generates more severe liver injury in older subjects
Specific Aim 3: Identify and analyze aging-related changes in patients with alcohol-associated liver disease
in relation to the severity of liver disease
酒精相关性肝病(ALD)是世界范围内发病率和死亡率的主要原因。它有一个数组
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kusum K. Kharbanda其他文献
615 Epigenetic Regulation of iNOS, PPAR-Alpha, and Dnmt1 in the Cystathionine Beta Synthase Deficient Mouse Model of Alcoholic Steatohepatitis
- DOI:
10.1016/s0016-5085(13)63543-x - 发表时间:
2013-05-01 - 期刊:
- 影响因子:
- 作者:
Valentina Medici;Diane I. Schroeder;Rima Woods;Janine M. LaSalle;Sanjana Dayal;Hidekazu Tsukamoto;Kusum K. Kharbanda;Samuel W. French;Charles H. Halsted - 通讯作者:
Charles H. Halsted
Kusum K. Kharbanda的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kusum K. Kharbanda', 18)}}的其他基金
Impaired methylation alters lipid droplet dynamics in liver and adipose tissue: Role in hepatic steatosis
甲基化受损改变肝脏和脂肪组织中的脂滴动力学:在肝脂肪变性中的作用
- 批准号:
10265320 - 财政年份:2019
- 资助金额:
$ 24.18万 - 项目类别:
Impaired methylation alters lipid droplet dynamics in liver and adipose tissue: Role in hepatic steatosis
甲基化受损改变肝脏和脂肪组织中的脂滴动力学:在肝脂肪变性中的作用
- 批准号:
10427223 - 财政年份:2019
- 资助金额:
$ 24.18万 - 项目类别:
Impaired methylation alters lipid droplet dynamics in liver and adipose tissue: Role in hepatic steatosis
甲基化受损改变肝脏和脂肪组织中的脂滴动力学:在肝脂肪变性中的作用
- 批准号:
10620687 - 财政年份:2019
- 资助金额:
$ 24.18万 - 项目类别:
Impaired phospholipid methylation results in decreased lipid droplet lipolysis: Role in hepatic steatosis
磷脂甲基化受损导致脂滴脂肪分解减少:在肝脂肪变性中的作用
- 批准号:
9900698 - 财政年份:2018
- 资助金额:
$ 24.18万 - 项目类别:
Impaired phospholipid methylation results in decreased lipid droplet lipolysis: Role in hepatic steatosis
磷脂甲基化受损导致脂滴脂肪分解减少:在肝脂肪变性中的作用
- 批准号:
10397177 - 财政年份:2018
- 资助金额:
$ 24.18万 - 项目类别:
Alcohol and smoking concurrently aggravate chronic pancreatitis
饮酒和吸烟同时加重慢性胰腺炎
- 批准号:
9569575 - 财政年份:2017
- 资助金额:
$ 24.18万 - 项目类别:
Effect of Alcohol on Hepatic Creatine Biosynthesis: Role of Defective Methylation
酒精对肝脏肌酸生物合成的影响:缺陷甲基化的作用
- 批准号:
8438194 - 财政年份:2012
- 资助金额:
$ 24.18万 - 项目类别:
Effect of Alcohol on Hepatic Creatine Biosynthesis: Role of Defective Methylation
酒精对肝脏肌酸生物合成的影响:缺陷甲基化的作用
- 批准号:
8327499 - 财政年份:2012
- 资助金额:
$ 24.18万 - 项目类别:
Effect of Alcohol on Hepatic Creatine Biosynthesis: Role of Defective Methylation
酒精对肝脏肌酸生物合成的影响:缺陷甲基化的作用
- 批准号:
8696831 - 财政年份:2012
- 资助金额:
$ 24.18万 - 项目类别:
Effect of Alcohol on Hepatic Creatine Biosynthesis: Role of Defective Methylation
酒精对肝脏肌酸生物合成的影响:缺陷甲基化的作用
- 批准号:
8803254 - 财政年份:2012
- 资助金额:
$ 24.18万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 24.18万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 24.18万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 24.18万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 24.18万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 24.18万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 24.18万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 24.18万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 24.18万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 24.18万 - 项目类别:














{{item.name}}会员




